Stabilize Biomolecules with Excipients
WEBINAR
A stable formulation is critical to ensure the desired therapeutic activity and safety of biologics. Mechanical stresses during manufacturing and transportation and certain storage conditions can lead to protein destabilization and aggregation. By minimizing interface interactions and increasing solubility, surfactants can stabilize proteins. Polysorbates have been the most widely used surfactants in biologics due to their biocompatibility and low toxicity. However, over the past decade challenges associated with the stability of polysorbates have been encountered. To reduce these quality issues, alternative surfactants, such as poloxamer 188 are considered in biomolecule formulations.
In this webinar, you will learn:
- The role of surfactants as stabilizers in biopharmaceuticals
- The advantages/disadvantages of using the various marketed surfactant in biomolecule surfactants
- The impacts of impurities in excipients on the formulation stability
Speaker

Nelli Erwin
Merck
Strategic Product Manager
Nelli Erwin is a Strategic Product Manager for enzymes and chemicals supporting novel modalities at our company, Darmstadt. With a PhD in Chemical Biology and experience across multiple R&D roles, she combines deep scientific expertise with a strong focus on innovation. Nelli drives high‑quality solutions that help customers advance their processes with confidence and accelerate progress in emerging therapeutic technologies.
Pharma and biopharma manufacturing
- Solid Formulation Strategies
Duration:58min
Language:English
Session 1:presented July 26, 2022
To continue reading please sign in or create an account.
Don't Have An Account?